InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,222.68
(
0.16%
)
US TECH 100
17,650.00
(
0.05%
)
Dow Jones
39,512.84
(
0.32%
)
Brent Oil
82.59
(
0.00%
)
Bitcoin
61,148.52
(
0.58%
)
Post# of 353140
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

TPX

Send PM Follow Ignore
Followers 0
Posts 40567
Boards Moderated 4
Alias Born 10/24/2013

TPX

Re: None

Friday, 12/09/2016 9:46:22 AM

Friday, December 09, 2016 9:46:22 AM

Post# of 353140
$PMCB THERE IS WRITTEN: AT-THE-MARKET AGREEMENT FOR PHARMACYTE BIOTECH, INC.
Represented PharmaCyte Biotech, Inc., a clinical-stage international biotechnology company providing cell and gene therapy solutions, in an “at the market” banking agreement with Chardan Capital Markets, LLC of up to $50 million.

http://www.loeb.com/experience-pharmacytebiotechatthemarketoffering

>>> Trip Advisor IS A GROWING STOCK PICK BOARD NOW <<<

Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up